Genome&Company
Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.
314130 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 수원시 영통구 창룡대로256번길 50 7층, 8층, 수원시
- Website:
- http://genomecom.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Genome & Company is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics. The company's core research and development programs are centered on microbiome-based pharmaceuticals, novel immune checkpoint inhibitors, and antibody-drug conjugates (ADCs). Its primary therapeutic area is immuno-oncology, aiming to develop new treatments for various cancers. Genome & Company utilizes its proprietary drug discovery platform to advance its pipeline through clinical trials and strategic partnerships, including the out-licensing of its drug candidates to global pharmaceutical firms.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-21 00:00 |
M&A Activity
주요사항보고서(타법인주식및출자증권양도결정)
|
Korean | 20.7 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.8 MB | ||
| 2025-08-08 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 68.4 KB | ||
| 2025-08-07 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 103.3 KB | ||
| 2025-07-18 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 77.8 KB | ||
| 2025-07-18 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 68.8 KB | ||
| 2025-07-17 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 80.9 KB | ||
| 2025-07-10 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 5.7 KB | ||
| 2025-07-02 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 186.7 KB | ||
| 2025-07-02 00:00 |
M&A Activity
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
|
Korean | 177.1 KB | ||
| 2025-06-04 00:00 |
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 8.7 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.7 MB | ||
| 2025-05-09 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 95.9 KB | ||
| 2025-05-09 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2025-05-09 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 103.6 KB |
Automate Your Workflow. Get a real-time feed of all Genome&Company filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Genome&Company via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
